Details of the Drug-Related molecule(s) Interaction Atlas

General Information of Drug (ID: DMX8C6J)

Drug Name

HCB1019 Drug Info

Indication

Disease Entry	ICD 11	Status	REF
Diabetic macular edema	9B71.02	Phase 2	[1]

Cross-matching ID

Molecule-Related Drug Atlas

Molecule Type:

DTT

Drug Status:

Clinical Trial Drug(s)

Investigative Drug(s)

Download the Complete Related Drug List

Drug(s) Targeting Gap junction alpha-1 protein (GJA1)

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
Granexin gel	DMZS2R7	Diabetic foot ulcer	BD54	Phase 3	[2]
Act1	DMXYRPO	Wound healing	EL8Y	Phase 3	[3]
ALMB-0168	DMB0LSF	Osteosarcoma	2B51	Phase 1/2	[4]
ALMB-0166	DM3MH2H	Spinal cord injury	ND51.2	Phase 1	[5]
octanol	DMBGHPE	Discovery agent	N.A.	Investigative	[6]
------------------------------------------------------------------------------------

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Download the Complete Interaction Atlas for Visualization in Cytoscape

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
Gap junction alpha-1 protein (GJA1)	TT4F7SL	CXA1_HUMAN	Inhibitor	[1]

------------------------------------------------------------------------------------

References

1	Clinical pipeline report, company report or official report of OcuNexus Therapeutics.
2	Antibodies and venom peptides: new modalities for ion channels. Nat Rev Drug Discov. 2019 May;18(5):339-357.
3	Company report (FirstString Research)
4	Clinical pipeline report, company report or official report of AlaMab Therapeutics
5	Clinical pipeline report, company report or official report of AlaMab Therapeutics
6	URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 728).